Erythropoietin-induced glioma and cervical cancer cells treated with tyrphostin B42, an inhibitor of JAK2 tyrosine kinase activity. JAK2 is an effector of EPOR.EPOR knockdown in GBM. Here, JAK2 is linked to central nervous system cancer.